ARCTArcturus Therapeutics Holdings Inc.
$6.82-49% 1Y
$6.82
$5.5252 weeks$23.16
The financials
Arcturus Therapeutics Holdings Inc. by the numbers
Arcturus Therapeutics Holdings Inc. (ARCT) reported revenue of $3.0M in Q2 2026 (quarter ended Jun 30, 2026), down 90% from the same quarter a year earlier. That came with net loss of $24M. For the full year FY2025, revenue was $82M (−46% year on year) and net income −$66M. The next results filing is expected around Nov 9, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $3.0M | $28M | −90% |
| Operating income | −$26M | −$12M | n/a |
| Net income | −$24M | −$9.2M | n/a |
| Diluted EPS | −$0.84 | −$0.34 | n/a |